Un argentino fundador de cinco unicornios vendió su empresa de biotecnología por más de US$1380 millones

Resumen del corpus

Martín Varsavsky, founder of five unicorns, announced that Ferring Pharmaceuticals, a Swiss pharmaceutical manufacturer, has acquired Gameto, his biotechnology company specializing in fertility, for $1.382.5 million. This acquisition marks the sale of Gameto, his sixth unicorn, and is part of a broader strategy to advance fertility treatments. Gameto's product, Fertilo, aims to reduce hormonal injections in fertility treatments, and the deal is seen as a strategic move to secure the future of fertility technology.